← Leaderboards
Henry J. Pownall
Methodist Hospital Research Institute
$10,844,928
Attributed
$13,948,695
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,948,695 · 16
By mechanism
R01$13,574,306 · 5
M01$191,716 · 1
P41$182,673 · 10
Top collaborators
- Corina Rosales8 shared
- Khurram Nasir3 shared
Most similar at Methodist Hospital Research Institute
Same institution · by research overlap
- Corina Rosales$1,978,738
Others in their field
Top investigators on “High Density Lipoproteins”
- Daniel James Rader · University Of Pennsylvania$45,161,673
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$32,518,468
- Richard T D'aquila · Massachusetts General Hospital$27,454,413
- Steven Kyle Grinspoon · Massachusetts General Hospital$24,968,109
- Alan Richard Tall · Columbia University Health Sciences$24,241,820
- Pamela Susan Douglas · Duke University$24,138,491
Research focus
High Density LipoproteinsLipidsMacrophageCholesterolPlasmaCholesterol EstersSurfaceProteinsPhospholipidsHigh Density Lipoprotein CholesterolParticleApolipoproteinsLipoproteinsRisk FactorsReverse Cholesterol TransportHepaticPharmaceutical PreparationsLdl Cholesterol LipoproteinsAtherosclerosisLiverMolecularOpacity FactorProtein Structure FunctionHepatocyte
Grant awards (46)
Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol$748,155
R01 · FY2025 · HL · contact PI
Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol$736,357
R01 · FY2024 · HL · contact PI
Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol$765,547
R01 · FY2023 · HL · contact PI
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability$403,750
R01 · FY2023 · HL · contact PI
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability$403,750
R01 · FY2022 · HL · contact PI
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability$403,750
R01 · FY2021 · HL · contact PI
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability$403,750
R01 · FY2020 · HL · contact PI
High Density Lipoprotein Biogenesis and Speciation$580,616
R01 · FY2019 · HL · contact PI
High Density Lipoprotein Biogenesis and Speciation$580,616
R01 · FY2018 · HL · contact PI
High Density Lipoprotein Biogenesis and Speciation$580,616
R01 · FY2017 · HL · contact PI
High Density Lipoprotein Biogenesis and Speciation$600,627
R01 · FY2016 · HL · contact PI
Atheroregression via Enhanced Reverse Cholesterol Transport$586,323
R01 · FY2015 · HL · contact PI
Atheroregression via Enhanced Reverse Cholesterol Transport$582,620
R01 · FY2014 · HL · contact PI
Atheroregression via Enhanced Reverse Cholesterol Transport$590,503
R01 · FY2012 · HL · contact PI
Atheroregression via Enhanced Reverse Choleserol Transport$603,540
R01 · FY2011 · HL · contact PI
LDL$12,256
P41 · FY2011 · RR · contact PI
HDL WITH SOF$4,912
P41 · FY2011 · RR · contact PI
Therapeutic Approaches to Dysregulated HDL Metabolism$568,539
R01 · FY2010 · HL · contact PI
Enzymatic Reactions of Plasma Lipoproteins$230,250
R01 · FY2010 · HL · contact PI
Enzymatic Reactions of Plasma Lipoproteins$85,960
R01 · FY2010 · HL · contact PI
LDL$21,500
P41 · FY2010 · RR · contact PI
HDL WITH SOF$21,500
P41 · FY2010 · RR · contact PI
Therapeutic Approaches to Dysregulated HDL Metabolism$607,496
R01 · FY2009 · HL · contact PI
Enzymatic Reactions of Plasma Lipoproteins$316,540
R01 · FY2009 · HL · contact PI
HDL WITH SOF$17,381
P41 · FY2009 · RR · contact PI
LDL$17,381
P41 · FY2009 · RR · contact PI
Enzymatic Reactions of Plasma Lipoproteins$314,288
R01 · FY2008 · HL · contact PI
Enzymatic Reactions of Plasma Lipoproteins$28,585
R01 · FY2008 · HL · contact PI
HDL AND SOF$16,231
P41 · FY2008 · RR · contact PI
Enzymatic Reactions of Plasma Lipoproteins$254,876
R01 · FY2007 · HL · contact PI
LDL$16,288
P41 · FY2007 · RR · contact PI
LDL$15,059
P41 · FY2006 · RR · contact PI
Lipid Transfer Mechanisms$338,625
R01 · FY2005 · HL
LDL$18,469
P41 · FY2005 · RR
Lipid Transfer Mechanisms$338,625
R01 · FY2004 · HL
Enzymatic reactions of Plasma Lipoproteins$188,125
R01 · FY2004 · HL
LDL$21,696
P41 · FY2004 · RR
Lipid Transfer Mechanisms$338,625
R01 · FY2003 · HL
Enzymatic reactions of Plasma Lipoproteins$188,125
R01 · FY2003 · HL
Lipid Transfer Mechanisms$363,625
R01 · FY2002 · HL
Enzymatic reactions of Plasma Lipoproteins$188,125
R01 · FY2002 · HL
Enzymatic reactions of Plasma Lipoproteins$210,600
R01 · FY2001 · HL
ALCOHOL &DIETARY HYPERTRIGLYCERIDEMIA$155,764
M01 · FY2001 · RR
LIPID TRANSFER MECHANISMS$283,456
R01 · FY2000 · HL
ENZYMATIC REACTIONS OF PLASMA LIPOPROTEINS$159,321
R01 · FY2000 · HL
ALCOHOL &DIETARY HYPERTRIGLYCERIDEMIA$35,952
M01 · FY2000 · RR